Publication

Those authors presenting papers at the Symposium are invited to submit full papers on either original research presented in the paper, or reviews in the field that has been covered in their talk for consideration as publications in Inflammopharmacology. Article submitted will be fast tracked for peer-review and publication on-line (www.Springer.com/10787) and subsequently in paper format in the published journal.

Authors intending to submit papers to Inflammopharmacology should consult the publisher's website www.Springer.com/10787 for details about the format and style of papers. Review papers may extend to 15-20 double-spaced typewritten in length with up to 6 figures and 4 tables (excluding references). Original research publications may extend to 10 pages (excluding references) with 6 figures and 4 tables. Short Communications may be up 6 double-spaced pages in length.

Any queries may be addressed to the Editor-in-Chief, Professor K D Rainsford at the following address: Professor KD Rainsford, PhD, FRCPEdin, FRCPath, FRSC, FSB, FIBMS, Dr(hc)
Emeritus Professor of Biomedical Sciences & Editor-in-Chief, INFLAMMOPHARMACOLOGY Biomedical Research Centre, Sheffield Hallam University Howard Street, Sheffield, S1 1WB, UK Email address: editor@inflammopharmacology.com
Attention: Budapest Symposium"